Imatinib in Philadelphia chromosome-positive chronic phase CML patients: Molecular and cytogenetic response rates and prediction of clinical outcome-Reference-Cited by-同舟云学术

Imatinib in Philadelphia chromosome-positive chronic phase CML patients: Molecular and cytogenetic response rates and prediction of clinical outcome

Published:2003-07-18 Issue:4 Volume:73 Page:249-255
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am. J. Hematol.

Author:

le Coutre Philipp,Kreuzer Karl-Anton,Na Il-Kang,Schwarz Michaela,Lupberger Joachim,Holdhoff Matthias,Baskaynak G�kben,Gschaidmeier Harald,Platzbecker Uwe,Ehninger Gerhard,Prejzner Witold,Huhn Dieter,Schmidt Christian A.

Publisher

Wiley

Subject

Hematology

Reference18 articles.

1. Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr–Abl positive cells

2. Inhibition of the ABL Kinase Activity Blocks the Proliferation of BCR/ABL+Leukemic Cells and Induces Apoptosis

3. The Tyrosine Kinase Inhibitor CGP57148B Selectively Inhibits the Growth of BCR-ABL–Positive Cells

4. In Vivo Eradication of Human BCR/ABL-Positive Leukemia Cells With an ABL Kinase Inhibitor

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Can integrative biomarker approaches improve prediction of platinum and PARP inhibitor response in ovarian cancer?;Seminars in Cancer Biology;2021-12

2. Comparison of the Cytogenetic and Molecular Analyses in the Assessment of Imatinib Response in Chronic Myelocytic Leukemia;Genetic Testing and Molecular Biomarkers;2009-10

3. Suboptimal responses in chronic myeloid leukemia: milestones and mechanisms;Expert Review of Hematology;2009-02

4. Lack of ABC transporter autoinduction in mice following long-term exposure to imatinib;Cancer Biology & Therapy;2008-03

5. Characterization of a reference material for BCR-ABL (M-BCR) mRNA quantitation by real-time amplification assays: towards new standards for gene expression measurements;Leukemia;2007-05-03